We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report.
- Authors
Correa e Castro, Ana Carolina; de Araujo, Andressa Alexandre; Botelho, Mariana Coelho; Nascimento, João Bosco; de Souza, Rafaela Marchon; Gadelha, Monica Roberto; Nardi, Antonio E.; Violante, Alice Helena Dutra
- Abstract
Prolactinomas are the most prevalent functional pituitary adenomas. They are usually treated clinically with dopamine agonists. The most widely used and suitable drug is cabergoline (CAB), a specific D2 dopamine agonists. Patients in prolactinoma treatment with CAB commonly report physical side effects, but aberrant behavioral changes such as increased impulsivity have also been reported recently. We report the case of a 47-year-old Brazilian woman with prolactinoma that developed compulsive buying, binge eating, and hypersexuality after four years of CAB treatment. In her psychiatric evaluation, the patient scored high levels on the following scales: Compulsive Buying Scale (CBS), Binge Eating Scale (BES), and Barratt Impulsiveness Scale-11 (BIS11). She also reported financial problems and weight gain in addition to her social and clinical problems. Impulsivity disorders may appear with the use of CAB and other dopamine agonists. We suggest that more observational studies with a large patient sample and specific regular psychiatric evaluations during treatment are necessary for patients in use of CAB, especially those treated for several years.
- Subjects
COMPULSIVE eating; COMPULSIVE shopping; PROLACTINOMA; BINGE-eating disorder; CABERGOLINE; COMPULSIVE behavior
- Publication
Frontiers in Psychiatry, 2022, Vol 13, p1
- ISSN
1664-0640
- Publication type
Article
- DOI
10.3389/fpsyt.2022.844718